Baxter Hlthcare Company Profile

✉ Email this page to a colleague

BAXTER HLTHCARE has two hundred and eighteen approved drugs.

There are twenty-one US patents protecting BAXTER HLTHCARE drugs. There are two tentative approvals on BAXTER HLTHCARE drugs.

There are thirty-seven patent family members on BAXTER HLTHCARE drugs in thirteen countries and three hundred and two supplementary protection certificates in sixteen countries.

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare Corp	NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE	norepinephrine bitartrate	SOLUTION;INTRAVENOUS	214313-001	Jan 15, 2021		RX	Yes	Yes		⤷ Sign Up				⤷ Sign Up
Baxter Hlthcare	CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER	cephalothin sodium	INJECTABLE;INJECTION	062422-006	Jul 16, 1991		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Baxter Hlthcare	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER	dextrose; potassium chloride; sodium chloride	INJECTABLE;INJECTION	018629-001	Mar 23, 1982	AP	RX	No	No		⤷ Sign Up				⤷ Sign Up
Baxter Hlthcare	PROCHLORPERAZINE	prochlorperazine edisylate	INJECTABLE;INJECTION	087759-001	Oct 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Baxter Hlthcare Corp	GRANISETRON HYDROCHLORIDE	granisetron hydrochloride	INJECTABLE;INJECTION	078198-002	Jun 30, 2008		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Baxter Hlthcare	CYTOXAN (LYOPHILIZED)	cyclophosphamide	INJECTABLE;INJECTION	012142-008	Jan 4, 1984	4,537,883	⤷ Sign Up
Baxter Hlthcare	NEXTERONE	amiodarone hydrochloride	INJECTABLE;INJECTION	022325-001	Dec 24, 2008	6,869,939	⤷ Sign Up
Baxter Hlthcare Corp	ZOSYN IN PLASTIC CONTAINER	piperacillin sodium; tazobactam sodium	INJECTABLE;INJECTION	050750-002	Feb 24, 1998	8,133,883	⤷ Sign Up
Baxter Hlthcare	IFEX/MESNEX KIT	ifosfamide; mesna	INJECTABLE;INJECTION	019763-004	Oct 10, 1992	5,696,172	⤷ Sign Up
Baxter Hlthcare	EXTRANEAL	icodextrin	SOLUTION;INTRAPERITONEAL	021321-001	Dec 20, 2002	6,248,726	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Inhalation	99.90%	➤ Subscribe	2008-09-11
➤ Subscribe	Injection	10 mg/mL, 250 mL infusion bags and 20 mg/mL, 100 mL infusion bags	➤ Subscribe	2014-01-31

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration
Hong Kong	1219883	⤷ Sign Up
European Patent Office	2268269	⤷ Sign Up
Canada	3170514	⤷ Sign Up
World Intellectual Property Organization (WIPO)	2009134347	⤷ Sign Up
Japan	2015110671	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0392059	0290025-6	Sweden	⤷ Sign Up	PRODUCT NAME: MEMANTIN, 1-AMINO-3,5-DIMETYLADAMANTAN; REGISTRATION NO/DATE: EU/1/02/219/001 20020515
0302769	SPC/GB98/039	United Kingdom	⤷ Sign Up	PRODUCT NAME: PURIFIED SOYABEAN OIL IN COMBINATION WITH PURIFIED OLIVE OIL.; REGISTERED: FR NL 19107 19951128; UK 00116/0313 19980730
1856135	CA 2020 00018	Denmark	⤷ Sign Up	PRODUCT NAME: FOSTAMATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, OR A HYDRATE, SOLVATE OR N-OXIDE OF FOSTAMATINIB OR THE PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, ESPECIALLY FOSTAMATINIB DISODIUM, OPTIONALLY IN FORM OF A HYDRATE; REG. NO/DATE: EU/1/19/1405 20200113
1280520	C01280520/01	Switzerland	⤷ Sign Up	PRODUCT NAME: TOBRAMYCIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 60565 01.02.2012
1441735	2008/010	Ireland	⤷ Sign Up	PRODUCT NAME: RALTEGRAVIR OR A PHARMECEUTICALLY ACCEPTABLE SALT THEREOF, ESPECIALLY THE POTASSIUM SALT; NAT AUTHORISTION NO/DATE: EU/1/07/436/001-002 20071220;
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.